Administration of antisense DNA for hepatocyte growth factor causes an depressive and anxiogenic response in rats

Neuropeptides

Volumn 41, Issue 6, 2007, Pages 477-483

  Wakatsuki, Masatoshi ^a   Akiyoshi, Jotaro ^a   Ichioka, Shugo ^a   Tanaka, Yoshihiro ^a   Tsuru, Jusen ^a   Matsushita, Hirotaka ^a   Hanada, Hiroaki ^a   Isogawa, Koichi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Antisense; Anxiety; Hepatocyte growth factor; Hippocampus; Rat

Indexed keywords

COMPLEMENTARY DNA; OLIGONUCLEOTIDE; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEAR; FORCED SWIMMING TEST; HIPPOCAMPUS; IMMOBILIZATION; LATERAL BRAIN VENTRICLE; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; DNA, ANTISENSE; HEPATOCYTE GROWTH FACTOR; LATERAL VENTRICLES; MALE; RATS; RATS, WISTAR;

RATTUS;

EID: 36048957177     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2007.07.001     Document Type: Article

References (35)

1. Achim C.L., Katyal S., Wiley C.A., Shiratori M., Wang G., Oshika E., Petersen B.E., Li J.-M., and Michalopoulos G.K. Expression of HGF and c-met in the developing and adult brain. Developmental Brain Research 102 (1997) 299-303
2. Aoki M., Morishita R., Taniyama Y., Kida I., Moriguchi A., Matsumoto K., Nakamura T., Kaneda Y., Higaki J., and Ogihara T. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Therapy 7 (2000) 417-427
3. Ban, Y., Watanabe, T., Miyazaki, A., Nakano, Y., Tobe. T., Idei, T., Iguchi, T., Ban, Y., Katagiri, T., 2006. Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia. Atherosclerosis (in press).
4. Bowers D.C., Fan S., Walter K., Abounader R., Williams J.A., Rosen E.M., and Laterra J. Scatter factor/hepatocyte growth factor activates AKT and protects against cytotoxic death in human glioblastoma via PI3-kinase and AKT-dependent pathways. Cancer Research 60 (2000) 4277-4283
5. De Frances M., Wolf H., Michalopoulos G.K., and Zarnegar R. The presence of hepatocyte growth factor in the developing rat. Development 116 (1992) 387-395
6. Detke M.J., Johnson J., and Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Experimental and Clinical Psychopharmacology 5 (1997) 107-112
7. Di Renzo M.F., Bertolotto A., Olivero M., Crepaldi T., Pagni C.A., and Comoglio P.M. Selective expression of the met/HGF receptor in human central nervous system microglia. Oncogene 8 (1993) 219-222
8. Ebens A., Brose K., Leonardo E.D., Hanson M.G., JrBladt F., Birchmeier C., Barres B.A., and Tessier-Lavigne M. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 17 (1996) 1157-1172
9. Fan S., Ma Y.X., Wang J., Yuan R., Meng Q., Cao Y., Laterra J., Goldberg I.D., and Rosen E.M. The cytokine scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3′ kinase. Oncogene 19 (2000) 2212-2223
10. Furge K.A., Zhang Y.W., and Vande Woude G.F. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 19 (2000) 5582-5589
11. Hamanoue M., Takemoto N., Matsumoto K., Nakamura T., Nakajima K., and Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. Journal of Neuroscience Research 43 (1996) 554-564
12. Hayashi S., Morishita R., Nakamura S., Yamamoto K., Moriguchi A., Nagano T., Taizi M., Noguchi H., Matsumoto K., Nakamura T., Higaki J., and Ogihara T. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: down-regulation of HGF in response to hypoxia in vascular cells. Circulation 100 (1999) II301-II308
13. Hayashi K., Morishita R., Nakagami H., Yoshimura S., Hara A., Matsumoto K., Nakamura T., Kaneda Y., Ogihara T., and Sakai N. Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons. Gene Therapy 8 (2001) 1167-1173
14. Honda S., Kagoshima M., Wanaka A., Tohyama M., Matsumoto K., and Nakamura T. Localization and functional coupling of HGF and c-met/HGF receptor in rat brain: Implication as neurotrophic factor. Molecular Brain Research 32 (1995) 197-210
15. Isogawa K., Akiyoshi J., Kodama K., Matsushita H., Tsutsumi T., Funakoshi H., and Nakamura T. Anxiolytic effect of hepatocyte growth factor infused into rat brain. Neuropsychobiology 51 (2005) 34-38
16. Jung W., Castrén E., Odenthal M., Vande Woude G., Dienes H.P., Lindholm D., and Schirmacher P. Expression and functional interaction of hepatocyte growth factor-scatter factor (HGF-SF) and its receptor c-met in mammalian brain. Journal of Cell Biology 126 (1994) 485-494
17. Korhonen L., Sjoholm U., Takei N., Kern M.A., Schirmacher P., Castren E., and Lindholm D. Expression of c-Met in developing rat hippocampus: evidence for HGF as a neurotrophic factor for calbindin D-expressing neurons. European Journal of Neuroscience 12 (2000) 3453-3461
18. Levitt P. Disruption of interneuron development. Epilepsia 46 Suppl 7 (2005) 22-28
19. Maina F., Hilton M.C., Ponzetto C., Davies A.M., and Klein R. Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. Genes and Development 11 (1997) 3341-3350
20. Maina F., Hilton M.C., Andres R., Wyatt S., Klein R., and Davies A.M. Multiple roles for hepatocyte growth factor in sympathetic neuron development. Neuron 20 (1998) 835-846
21. Miyazawa T., Matsumoto K., Ohmichi H., Katoh H., Yamashima T., and Nakamura T. Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. Journal of Cerebral Blood Flow and Metabolism 18 (1998) 345-348
22. Morishita R., Nakamura S., Hayashi S., Taniyama Y., Moriguchi A., Nagano T., Taiji M., Noguchi H., Takeshita S., Matsumoto K., Nakamura T., Higaki J., and Ogihara T. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as "cytokine supplement therapy". Hypertension 33 (1999) 1379-1384
23. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., and Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 342 (1989) 440-443
24. Park M., Dean M., Kaul K., Braun M.J., Gonda M.A., and Vande Woude G.F. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proceedings of the National Academy of Sciences USA 84 (1987) 6379-6383
25. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to depressant treatments. Nature 266 (1977) 730-732
26. Powell E.M., Campbell D.B., Stanwood G.D., Davis C., Noebels J.L., and Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. Journal of Neuroscience 23 (2003) 622-631
27. Rosen E.M., Nigam S.K., and Goldberg I.D. Scatter factor and the c-met receptor: a paradigm for mesenchymal epithelial interaction. Journal of Cell Biology 127 (1994) 1783-1787
28. Streit A., Stern C.D., Thery C., Ireland G.W., Aparicio S., Sharpe M.J., and Gheradi E. A role for HGF/SF in neural induction and its expression in Hensen's node during gastrulation. Development 121 (1995) 813-824
29. Tashiro K., Hagiya M., Nishizawa T., Sekim T., Shimonishi M., Shimizu S., and Nakamura T. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proceeding of the National Academy of Sciences USA 87 (1990) 3200-3204
30. Tsuboi Y., Kakimoto K., Nakajima M., Akatsu H., Yamamoto T., Ogawa K., Ohnishi T., Daikuhara Y., and Yamada T. Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease. Acta Neurologica Scandinavica 107 (2003) 81-86
31. Watanabe T., Yamamoto H., Idei T., Iguchi T., and Katagiri T. Influence of insulin-like growth factor-1 and hepatocyte growth factor on carotid atherosclerosis and cognitive function in the elderly. Dement and Geriatric Cognitive Disorders 18 (2004) 67-74
32. Wong V., Glass D.J., Arriaga R., Yancopoulos G.D., Lindsay R.M., and Conn G. Hepatocyte growth factor promotes motor neuron survival and synergizes with ciliary neurotrophic factor. Journal of Biological Chemistry 272 (1997) 5187-5191
33. Yamada K., Moriguchi A., Morishita R., Aoki M., Nakamura Y., Mikami H., Oshima T., Ninomiya M., Kaneda Y., Higaki J., and Ogihara T. Efficient oligonucleotide delivery using the HVJ-liposome method in the central nervous system. American Journal of Physiology 271 (1996) R1212-R1220
34. Yamamoto Y., Livet J., Pollock R.A., Garces A., de Arce V., Lapeyriére O., and Henderson C.E. Hepatocyte growth factor (HGF/SF) is a muscle-derived survival factor for a subpopulation of embryonic motoneurons. Development 124 (1997) 2903-2913
35. Zarnegar R., and Michalopoulos G. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. Journal of Cell Biology 129 (1995) 1177-1180